Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1001420-03-6

C13H14O6 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1001420-03-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1001420-03-6 Structure

  • Basic information

    1. Product Name: C13H14O6
    2. Synonyms: C13H14O6
    3. CAS NO:1001420-03-6
    4. Molecular Formula:
    5. Molecular Weight: 266.251
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1001420-03-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C13H14O6(CAS DataBase Reference)
    10. NIST Chemistry Reference: C13H14O6(1001420-03-6)
    11. EPA Substance Registry System: C13H14O6(1001420-03-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1001420-03-6(Hazardous Substances Data)

1001420-03-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1001420-03-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,1,4,2 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1001420-03:
(9*1)+(8*0)+(7*0)+(6*1)+(5*4)+(4*2)+(3*0)+(2*0)+(1*3)=46
46 % 10 = 6
So 1001420-03-6 is a valid CAS Registry Number.

1001420-03-6Downstream Products

1001420-03-6Relevant articles and documents

NOVEL GLUCOKINASE ACTIVATORS AND METHODS OF USING SAME

-

Page/Page column 87, (2008/06/13)

Compounds are provided which are phosphonate and phosphinate activators and thus are useful in treating diabetes and related diseases and have the structure wherein is a heteroaryl ring; R4 is —(CH2)n-Z-(CH2)m—PO(OR7)(OR8), —(CH2)nZ-(CH2)m—PO(OR7)Rg, —(CH2)n-Z-(CH2)m—OPO(OR7)Rg, —(CH2)nZ—(CH2)m—OPO(R9)(R10), or —(CH2)nZ—(CH2)m—PO(R9)(R10);R5 and R6 are independently selected from H, alkyl and halogen;Y is R7(CH2)s or is absent; andX, n, Z, m, R4, R5, R6, R7, and s are as defined herein; or a pharmaceutically acceptable salt thereof. A method for treating diabetes and related diseases employing the above compounds is also provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1001420-03-6